Freeze dryer or lyopholizer accessories

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

3-layer construction with soft outer covering, absorbent middle layer, film inner layer., Ice Pack, Large, 4 Ties, 6 x 14, 25/bx, 2 bx/cs (US Only)

Jumbosep Sample Reservoir and Cap, 12/pk

AED Plus, PS Series, ECG ON, w/ PA CVR, LCD, No Voice Recording, PlusRX, DMST

ZOLL AED 3 Fully Automatic Package, w/ Uni-Padz, 5 Year Battery (Item is considered HAZMAT and cannot ship via Air or to AK, GU, HI, PR, VI)

ZOLL AED 3 Semi-Automatic Package, w/ Uni-Padz, 5 Year Battery, Carry Case (Item is considered HAZMAT and cannot ship via Air or to AK, GU, HI, PR, VI)

ZOLL AED 3 BLS Package, w/ CPR Stat Padz, 5 Year Battery (Item is considered HAZMAT and cannot ship via Air or to AK, GU, HI, PR, VI)

Inorganic Ventures&#39 10,000 ppm Selenium for ICP is a certified reference material set in a nitric acid matrix for stability. This selenium standard is Traceable to NIST and manufactured in accordance with our stringent Quality Assurance

Lyciumin A, a cyclic octapeptide, exhibits inhibitory activity on proteases, renin and angiotensin-converting enzyme . Lyciumin A can be used for the research of hypertensionIn VitroLyciumin A inhibits renin activities by 19.4% (40 μg/mL). MCE has

Lyciumin A, a cyclic octapeptide, exhibits inhibitory activity on proteases, renin and angiotensin-converting enzyme . Lyciumin A can be used for the research of hypertensionIn VitroLyciumin A inhibits renin activities by 19.4% (40 μg/mL). MCE has

Laflunimus (HR325) is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). Laflunimus suppresses immunoglobulin (Ig) secretion,

Laflunimus (HR325) is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). Laflunimus suppresses immunoglobulin (Ig) secretion,